NEK7-KINASEHEMMER

European patent · EP4146348 · In force

Register entry

Publication number
EP4146348
Application number
EP21770328
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 7, 2021
Published
Mar 15, 2023
Granted
Jul 3, 2024
Protection ends at the latest
May 6, 2041
Next annual fee due
May 31, 2027
IPC classes
A61P 37/00 (2006.01)
C07D 487/04 (2006.01)
A61K 31/519 (2006.01)
Priority
US 202063022159 P 08.05.2020
US 202163170761 P 05.04.2021
PCT application
PCT/US2021/031394 07.05.2021
PCT publication
WO2021/242505 02.12.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. May 14, 2025

    Change

    Published in Swissreg on 14.05.2025

  4. Sep 24, 2024

    Agent entered

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 24.09.2024

  5. Jul 3, 2024

    Granted

    Published in Swissreg on 03.07.2024

Parties

Holder

Halia Therapeutics, Inc.

3900 North Traverse Mtn. Blvd. Suite 100, Lehi, UT 84043, US

Agent

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventor

MOLLARD, Alexis Henri Abel

Salt Lake City, Utah 84119, US

BEARSS, David James

Salt Lake City, Utah 84119, US

KAUWE III, John Sai Keong

Salt Lake City, Utah 84119, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.